These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34641809)

  • 1. Invasive pneumococcal disease burden in hospitalized adults in Bogota, Colombia.
    Narváez PO; Gomez-Duque S; Alarcon JE; Ramirez-Valbuena PC; Serrano-Mayorga CC; Lozada-Arcinegas J; Bastidas A; Gómez S; Vargas H; Feldman C; Reyes LF
    BMC Infect Dis; 2021 Oct; 21(1):1059. PubMed ID: 34641809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of
    Camacho Moreno G; Imbachi LF; Leal AL; Moreno VM; Patiño JA; Gutiérrez IF; Beltrán S; Álvarez-Olmos MI; Mariño C; Barrero R; Espinosa F; Ramos N; Castellar LP; Sánchez N; Montañez A
    Hum Vaccin Immunother; 2020 Sep; 16(9):2300-2306. PubMed ID: 32078398
    [No Abstract]   [Full Text] [Related]  

  • 3. Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia.
    Severiche-Bueno DF; Severiche-Bueno DF; Bastidas A; Caceres EL; Silva E; Lozada J; Gomez S; Vargas H; Viasus D; Reyes LF
    Int J Infect Dis; 2021 Apr; 105():32-39. PubMed ID: 33582374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
    Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
    Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Li L; Ambrose A; Hatchette TF; Lang AL; Gillis H; Martin I; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy A; McGeer A; Moraca S; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; McNeil SA;
    Vaccine; 2017 Jun; 35(29):3647-3654. PubMed ID: 28554501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Ambrose A; Hatchette TF; Lang ALS; Gillis HD; Martin I; Demczuk W; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy AE; McGeer A; Semret M; Trottier S; Valiquette L; Webster D; McNeil SA
    Vaccine; 2019 Aug; 37(36):5466-5473. PubMed ID: 31345638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.
    Africano HF; Serrano-Mayorga CC; Ramirez-Valbuena PC; Bustos IG; Bastidas A; Vargas HA; Gómez S; Rodriguez A; Orihuela CJ; Reyes LF
    Clin Infect Dis; 2021 Jun; 72(11):e711-e719. PubMed ID: 32964223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pneumococcal diseases in adults admitted to the Na Bulovce Hospital: Serotype replacement after the implementation of general childhood pneumococcal vaccination.
    Veselý D; Kříha MF; Džupová O; Kozáková J; Žemličková H; Sýkorová B; Nyčová E; Marešová V; Roháčová H; Pícha D; Rozsypal H; Trojánek M
    Epidemiol Mikrobiol Imunol; 2021; 70(1):10-17. PubMed ID: 33853333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential impact of PCV-13, PCV-15 and PCV-20 vaccines in Colombia.
    Serrano-Mayorga CC; Ibáñez-Prada ED; Restrepo-Martínez JM; Garcia-Gallo E; Duque S; Severiche-Bueno DF; Severiche-Bueno DF; Gomez S; Vargas H; Reyes LF
    Vaccine; 2024 Mar; 42(7):1435-1439. PubMed ID: 38336559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.
    Riva E; Salvini F; Garlaschi ML; Radaelli G; Giovannini M
    BMC Infect Dis; 2012 May; 12():106. PubMed ID: 22554011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
    Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
    Ruiz García Y; Nieto Guevara J; Izurieta P; Vojtek I; Ortega-Barría E; Guzman-Holst A
    Expert Rev Vaccines; 2021 Jan; 20(1):45-57. PubMed ID: 33507135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
    Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
    Brandileone MC; Almeida SCG; Minamisava R; Andrade AL
    Vaccine; 2018 May; 36(19):2559-2566. PubMed ID: 29650385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A pediatric case of pneumococcal meningitis due to Streptococcus pneumoniae serotype 35F].
    Kara SS; Polat M; Tapisiz A; Nar Otgun S; Tezer H
    Mikrobiyol Bul; 2014 Apr; 48(2):346-50. PubMed ID: 24819273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of patients who died of invasive pneumococcal disease in the child population of Bogota, Colombia].
    Rojas JP; Leal AL; Patiño J; Montañez A; Camacho G; Beltrán S; Bonilla C; Barrero R; Mariño C; Ramos N;
    Rev Chil Pediatr; 2016; 87(1):48-52. PubMed ID: 26627694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.